序号 |
标题 |
次数 |
作者 |
发布时间 |
811 |
CAS号2389064-47-3 DOTA-tris(TBE)-amido-dPEG4-TFP ester |
8 |
zyl |
2024-11-21 |
812 |
C13-R8的简单介绍 |
7 |
kx |
2024-11-21 |
813 |
DOTA-GGGF-ITC 齐岳定制 |
6 |
zcy |
2024-11-21 |
814 |
p-NH2-Bn-DOTA-四叔丁酯 |
5 |
zyl |
2024-11-21 |
815 |
CAS号:213187-44-1 DOTA-BIM-23014:DOTA-Lanreotide |
4 |
zyl |
2024-11-21 |
816 |
1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid-lanreotide 定制 |
5 |
zcy |
2024-11-21 |
817 |
DOTA-cyclo(RGDfK) acetate |
5 |
zyl |
2024-11-21 |
818 |
NHS-DOTA 齐岳供应 |
5 |
zcy |
2024-11-21 |
819 |
叠氮-PEG-氨基(N3-PEG-NH2) |
5 |
WYQ |
2024-11-21 |
820 |
CAS号:149819-85-2,Iron DOTA Sodium Salt |
5 |
zyl |
2024-11-21 |
821 |
叠氮化的5,10,15,20四苯基卟啉(PPN3) |
7 |
WYQ |
2024-11-21 |
822 |
金属螯合剂DOTA Acrylamide |
6 |
kx |
2024-11-21 |
823 |
双(2-叠氮基乙基)3,3'-(丙烷-2,2-二基双(硫代二烷基))二丙酸酯(TK-N3) |
7 |
WYQ |
2024-11-21 |
824 |
DOTA-PEG48-Cys-VS DOTA修饰的单分散PEG结合的巯基化双抗体 |
5 |
zcy |
2024-11-21 |
825 |
炔基功能化的聚谷氨酸(PPLG) |
7 |
WYQ |
2024-11-21 |
826 |
两亲性分子寡聚苯撑乙炔衍生物OPE-PEG-NH2 |
7 |
WYQ |
2024-11-21 |
827 |
DOTA-ACA,DOTA-丙烯酰胺,DOTA-Acrylamide |
5 |
kx |
2024-11-21 |
828 |
DOTA-(His)2-minigastrin 科研定制 |
6 |
zcy |
2024-11-21 |
829 |
DOTA-(His)2-minigastrin 科研定制 |
5 |
zcy |
2024-11-21 |
830 |
叠氮修饰的三嵌段聚合物PEG-b-P(BIEM-N3)-b-PtBA |
5 |
WYQ |
2024-11-21 |
831 |
DOTA-(Tyr3)-Octreotate |
5 |
kx |
2024-11-21 |
832 |
DOTA-PP-F11N DOTA-(dGlu) 齐岳供应 |
5 |
zcy |
2024-11-21 |
833 |
DOTA-E[c(RGDfK)2],DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys) |
5 |
kx |
2024-11-21 |
834 |
753421-63-5,DOTA-C4-NH2 |
7 |
kx |
2024-11-21 |
835 |
Ga-DOTA-TOC acetate,CAS号:293295-70-2 |
8 |
zyl |
2024-11-21 |
836 |
DOTA-D-Tat peptide stock solution (3 mM) 齐岳供应 |
5 |
zcy |
2024-11-21 |
837 |
DOTA-Acrylamide,DOTA-DBCO,DOTA-MeTz |
7 |
kx |
2024-11-21 |
838 |
DOTA-Knottin Peptide 齐岳定制 |
7 |
zcy |
2024-11-21 |
839 |
DOTA-RGD,DOTA多肽衍生物 |
10 |
kx |
2024-11-21 |
840 |
DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 |
5 |
zcy |
2024-11-21 |
841 |
DOTA-丙烯酰胺,DOTA Acrylamide |
8 |
kx |
2024-11-21 |
842 |
DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
6 |
zyl |
2024-11-21 |
843 |
1262403-91-7,七肽DOTA-YLYEIAR,螯合物前体肽 |
5 |
kx |
2024-11-21 |
844 |
DOTA-8-AOC-BBN (7-14)NH2 NOTA-共轭铃蟾肽衍生物 |
10 |
zcy |
2024-11-21 |
845 |
多叠氮基聚乙二醇衍生物(PEGn(N3))m |
8 |
WYQ |
2024-11-21 |
846 |
DOTA derivative,CAS号:153777-70-9 |
5 |
zyl |
2024-11-21 |
847 |
多炔基聚乙二醇衍生物(PEGn(C≡CH))m |
7 |
WYQ |
2024-11-21 |
848 |
173308-19-5,DOTA-(COOt-Bu)3-C2-NH2 |
5 |
kx |
2024-11-21 |
849 |
DOTA-ADIBO,CAS号:1374865-01-6 |
4 |
zyl |
2024-11-21 |
850 |
端炔基聚乙二醇(PEG-alk) |
8 |
WYQ |
2024-11-21 |
851 |
Gd-DOTA-HCBP(多肽核磁共振成像(MRI)探针) |
5 |
zyl |
2024-11-21 |
852 |
NOTA-IPB-PDL1P PET成像分子探针 |
6 |
zcy |
2024-11-21 |
853 |
DOTA大环化合物,Tm-DOTA,CAS号78063-83-9 |
6 |
zyl |
2024-11-21 |
854 |
DOTA-E[c(RGDyK)2],金属离子螯合剂 |
7 |
kx |
2024-11-21 |
855 |
DOTA-8-AOC-BOMBESIN(7-14)NH2 DOTA-8-AOC-铃蟾肽(7-14)氨基 |
8 |
zcy |
2024-11-21 |